Tag: Prescription Drugs
Semaglutide Reduces 10-Year Risk for T2D in Obese Persons
Sustained treatment with semaglutide needed to maintain reduction in risk for type 2 diabetes
Triplet Therapy Ups Progression-Free Survival in Advanced Kidney Cancer
PFS improved with cabozantinib + nivolumab + ipilimumab for patients with previously untreated advanced renal cell carcinoma
Continuation of Anti-TNF for IBD After 24 Weeks of Pregnancy Beneficial
Risk for maternal IBD relapse and prematurity reduced with continuation of anti-TNF after 24 weeks of pregnancy
Bebtelovimab Appears Reliable for COVID-19 During Omicron Epoch
Patients receiving bebtelovimab have more comorbidities, but do not have increased rates of progression to severe disease
Daily Timing of Antihypertensives Does Not Impact Effectiveness
Evening dosing of blood pressure medication no better than morning dosing
FDA Warns Against Overuse of TPOXX Monkeypox Drug
Agency says research in labs, animals, and people suggests that monkeypox could develop resistance to the antiviral in multiple ways
Dupilumab Eases Atopic Dermatitis in Children Younger Than 6 Years
Signs and symptoms of atopic dermatitis improved with dupilumab versus placebo in addition to topical corticosteroids
Twelfth Version of Living Guideline Issued for Drugs for COVID-19
New update strongly recommends against use of sotrovimab and casirivimab-imdevimab for patients with COVID-19
Bedaquiline-Pretomanid-Linezolid Regimens Compared for XDR TB
Overall risk-benefit ratio seems to favor patients receiving linezolid at dose of 600 mg for 26 weeks
Data Support Continued Access to Tecovirimat for Monkeypox
Median interval from initiation of tecovirimat to subjective improvement was three days
